Nitric oxide synthase inhibition blocks amphetamine-induced locomotor activity in mice

Drug and Alcohol Dependence

Volumn 56, Issue 2, 1999, Pages 109-113

  Çelik, Turgay ^a   Zaglí, Ünal ^a   Kayír, Hakan ^a   Uzbay, I Tayfun ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Amphetamine; Mice; N(G) Nitroarginine methyl ester; Nitric oxide; Psychostimulants

Indexed keywords

AMPHETAMINE; ARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AMPHETAMINE; ANIMALS; ARGININE; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; MALE; MICE; MOTOR ACTIVITY; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

EID: 0032791683     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(99)00031-9     Document Type: Article

References (35)

1. Abekawa T., Ohmori T., Koyama T. Effect of NO synthase inhibition on behavioral changes induced by single administration of metamphetamine. Brain. Res. 666:1994;147-150.
2. G-nitro-L-arginine methyl ester. Life Sci. 52:1993;245-249.
3. Adams M.L., Sewing B.N., Chen J., Meyer E.R., Cicero T.J. Nitric oxide-related agents alter alcohol withdrawal in male rats. Alcohol. Clin. Exp. Res. 19:1995;195-199.
4. Bredt D.S., Snyder S.H. Nitric oxide, a novel neuronal messenger. Neuron. 8:1992;3-11.
5. Crawford C.A., Drago J., Watson J.B., Levine M.S. Effects of repeated amphetamine treatment on the locomotor activity of the dopamine D1A-deficient mouse. Neuroreport. 8:1997;2523-2527.
6. Filip M., Przegalinski E. The role of nitric oxide (NO) pathway in the discriminative stimuli of amphetamine and cocaine. Pharmacol. Biochem. Behav. 59:1998;703-708.
7. Garthwaite J. Glutamate, nitric oxide and cell-cell signaling in the nervous system. Trends Neurosci. 14:1991;60-67.
8. Johanson C., Jackson D.M., Svenson L. Nitric oxide synthase inhibition blocks phencyclidine-induced behavioral effects on prepulse inhibition and locomotor activity in the rat. Psychopharmacology. 131:1997;167-173.
9. Kaputlu I., Uzbay I.T. L-NAME inhibits pentylenetetrazole and strychinine-induced seizures in mice. Brain Res. 753:1997;98-101.
10. Kelly P.H., Iversen S.D. Selective 6-OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats. Eur. J. Pharmacol. 40:1976;45-56.
11. Koob G.F. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci. 13:1992;177-184.
12. Koob F., Bloom F.E. Cellular and molecular mechanisms of drug dependence. Science. 242:1988;715-723.
13. Krebs M.O., Desce J.M., Kemel M.L., Gauchy C., Godeheu G., Cheramy A., Glowinski J. Glutamergic control of dopamine release in the rats striatum: evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic nerve terminals. J. Neurochem. 56:1991;81-85.
14. Leza J.-C., Lizasoain I., Cuéllar B., Moro M.A., Lorenzo P. Correlation between brain nitric oxide synthase activity and opiate withdrawal. Naunyn-Schmiedeberg's Arch. Pharmacol. 353:1996;349-354.
15. Moncada S., Higgs A. The L'-arginine-nitric oxide pathway. New Engl. J. Med. 329:1993;2002-2012.
16. G-nitro arginine methyl ester exhibits antinociceptive activity in the mouse. Br. J. Pharmacol. 102:1991;198-202.
17. Morley J.E., Flood J.F. Evidence that nitric oxide modulates food intake in mice. Life Sci. 49:1991;707-711.
18. Nelson R.J., Demas G.E., Huang P.L., Fishman M.C., Dawson V.L., Dawson T.M., Snyder S.H. Behavioral abnormalities in male mice lacking neuronal nitric oxide synthase. Nature. 378:1995;383-386.
19. Ohno M., Watanabe S. Nitric oxide synthase inhibitors block behavioral sensitization to metamphetamine in mice. Eur. J. Pharmacol. 275:1995;39-44.
20. Phillips A.G., Blaha C.D., Fibiger H.C. Neurochemical correlates of brain-stimulation reward measured by ex vivo and in vivo analyses. Neurosci. Biobehav. Rev. 13:1989;99-104.
21. Przegalinski E., Filip M. Nitric oxide (NO) pathway and locomotor hyperactivity towards dopaminimimetics in rats. Pol. J. Pharmacol. 49:1997;291-298.
22. Przewlocka B., Turchan J., Machelska H., Labuz D., Lason W. Nitric oxide synthase inhibitor L-NAME prevents amphetamine-induced prodynorphin gene expression in the rat. Prog. Neuropsychopharmacol. Biol. Psychiatry. 20:1996;1229-1237.
23. Pudiak C.M., Bozarth M.A. L-NAME and MK-801 attenuate sensitization to the locomotor-stimulating effect of cocaine. Life Sci. 53:1993;1517-1524.
24. Quock R.M., Nguyen E. Possible involvement of nitric oxide in chlordiazaepoxide-induced anxiolysis in mice. Life Sci. 51:1992;255-260.
25. Shimizu N., Duan S., Hori T., Oomura Y. Glutamate modulates dopamine release in the striatum as measured by brain microdialysis. Brain. Res. Bull. 25:1990;99-102.
26. Snyder S.H., Bredt D.S. Nitric oxide as a neuronal messenger. Trends. Pharmacol. Sci. 12:1991;125-128.
27. Stewart J., Deschamps S.-E., Amir S. Inhibition of nitric oxide synthase does not block the development of sensitization to the behavioral effects of amphetamine. Brain Res. 641:1994;141-144.
28. Stolerman I. Drugs of abuse: behavioral principles, methods and terms. Trends Pharmacol. Sci. 13:1992;170-176.
29. Uzbay I.T., Erden B.F., Tapanyigit E.E., Kayaalp S.O. Nitric oxide synthase inhibition attenuates signs of ethanol withdrawal in rats. Life Sci. 61:1997;2197-2209.
30. Uzbay I.T., Grewal J.S., Wallis C.J., Dungan L.F., Lal H. Nitric oxide synthase inhibition attenuates saccharin or ethanol reinforced responding in Long-Evans rats. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 22:1998;1411-1423.
31. Vaupel D.B., Kimes A.S., London E.D. Further in vivo studies on attenuating morphine withdrawal: isoform-selective nitric oxide synthase inhibitors differ in efficacy. Eur. J. Pharmacol. 324:1997;11-20.
32. Wise R.A., Bozarth M.A. A psychomotor stimulant theory of addiction. Psychol. Rev. 94:1987;469-497.
33. Wolf M.E., Khansa M.R. Repeated administration of MK-801 produces to its own locomotor stimulant effects but blocks sensitization to amphetamine. Brain. Res. 562:1991;164-168.
34. Woolverton W.L., Johnson K.M. Neurobiology of cocaine abuse. Trends Pharmacol. Sci. 13:1992;193-200.
35. Yamada K., Noda Y., Nakayama S., Komori Y., Sugihara H., Hasegawa T., Nabeshima T. Role of nitric oxide in learning and memory and in monoamine metabolism in the rat brain. Br. J. Pharmacol. 115:1995;852-858.